HHS launches two programs to tackle AI in drug safety and vaccine design
As fully covered on FederalNewsNetwork’s Federal Drive, Health and Human Services’ Advanced Research Projects Agency-Health (ARPA-H) launched two new initiatives to address complex biomedical challenges. The first, Catalyst, focuses on using AI tools to improve drug development by predicting human outcomes in preclinical phases, thus reducing the high failure